MDS Nordion brings new cyclotron online

Radioisotope developer MDS Nordion of Kanata, ON, has started commercial production at its TR-30-2 cyclotron in Vancouver, BC. The unit, the third at the firm’s Vancouver site, is authorized by the Canadian Nuclear Safety Commission (CNSC) for production of medical isotopes. The new cyclotron will produce a broad range of medical isotopes, including I-123, Pd-103, Tl-201, and In-111, according to the company.

By staff writers
June 17, 2003

Related Reading

MDS sells oncology software unit to Delft, February 11, 2003

MDS Nordion gets regulatory approvals, July 11, 2002

MDS Nordion focuses on oncology software solutions, June 28, 2002

Varian to buy MDS Nordion's brachytherapy unit, June 27, 2002

MDS expands manufacturing facilities, June 12, 2002

Copyright © 2003

Page 1 of 594
Next Page